1 June 2022 false No description of principal activity Taxfiler 2023.9 10791545business:PrivateLimitedCompanyLtd2022-06-012022-12-31 107915452022-05-31 107915452022-06-012022-12-31 10791545business:AuditExemptWithAccountantsReport2022-06-012022-12-31 10791545business:AbridgedAccounts2022-06-012022-12-31 107915452022-12-31 10791545business:Director12022-06-012022-12-31 10791545business:RegisteredOffice2022-06-012022-12-31 107915452022-05-31 10791545core:WithinOneYear2022-12-31 10791545core:WithinOneYear2022-05-31 10791545core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2022-12-31 10791545core:RetainedEarningsAccumulatedLossescore:PreviouslyStatedAmount2022-05-31 10791545core:PreviouslyStatedAmount2022-12-31 10791545core:PreviouslyStatedAmount2022-05-31 10791545business:SmallEntities2022-06-012022-12-31 10791545countries:EnglandWales2022-06-012022-12-31 10791545core:PlantMachinery2022-06-012022-12-31 10791545core:ComputerEquipment2022-06-012022-12-31 10791545core:OtherPropertyPlantEquipment2022-06-012022-12-31 107915452021-06-012022-05-31 iso4217:GBP xbrli:pure
Company Registration No. 10791545 (England and Wales)
Unium Bioscience Ltd Unaudited accounts for the period from 1 June 2022 to 31 December 2022
Unium Bioscience Ltd Unaudited accounts Contents
Page
- 2 -
Unium Bioscience Ltd Company Information for the period from 1 June 2022 to 31 December 2022
Director
Mr John Haywood
Company Number
10791545 (England and Wales)
Registered Office
The Old Barn Anchorage Lane, Sprotbrough Doncaster South Yorkshire DN5 8DT
Accountants
Campbell and Stenton Accountancy 17 Bridgegate Howden East Yorkshire DN14 7AE
- 3 -
Unium Bioscience Ltd Accountants' report
Accountants' report to the director of Unium Bioscience Ltd on the preparation of the unaudited statutory accounts for the period from 1 June 2022 to 31 December 2022
In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Unium Bioscience Ltd for the period from 1 June 2022 to 31 December 2022 as set out on pages 5 - 7 from the company's accounting records and from information and explanations you have given us.
This report is made solely to the Board of Directors of Unium Bioscience Ltd, as a body, in accordance with the terms of our engagement. Our work has been undertaken solely to prepare for your approval the accounts of Unium Bioscience Ltd and state those matters that we have agreed to state to them, as a body, in this report. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Unium Bioscience Ltd and its Board of Directors as a body for our work or for this report.
It is your duty to ensure that Unium Bioscience Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and loss of Unium Bioscience Ltd. You consider that Unium Bioscience Ltd is exempt from the statutory audit requirement for the period.
We have not been instructed to carry out an audit or a review of the accounts of Unium Bioscience Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.
Campbell and Stenton Accountancy 17 Bridgegate Howden East Yorkshire DN14 7AE 6 October 2023
- 4 -
Unium Bioscience Ltd Statement of financial position as at 31 December 2022
31/12/2022 
31/05/2022 
Notes
£ 
£ 
Fixed assets
Intangible assets
3,110 
3,110 
Tangible assets
5,817 
5,084 
Investments
1,015 
1,015 
9,942 
9,209 
Current assets
Inventories
957,260 
526,711 
Debtors
92,726 
735,890 
Cash at bank and in hand
124,372 
96,744 
1,174,358 
1,359,345 
Creditors: amounts falling due within one year
(430,029)
(317,359)
Net current assets
744,329 
1,041,986 
Net assets
754,271 
1,051,195 
Capital and reserves
Profit and loss account
754,271 
1,051,195 
Shareholders' funds
754,271 
1,051,195 
For the period ending 31 December 2022 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies. The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges his responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
The members have agreed to the preparation of abridged accounts for the period in accordance with Section 444(2A).
These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with the provisions of FRS 102 Section 1A - Small Entities. The profit and loss account has not been delivered to the Registrar of Companies.
The financial statements were approved by the Board and authorised for issue on 6 October 2023 and were signed on its behalf by
Mr John Haywood Director Company Registration No. 10791545
- 5 -
Unium Bioscience Ltd Notes to the Accounts for the period from 1 June 2022 to 31 December 2022
1
Statutory information
Unium Bioscience Ltd is a private company, limited by shares, registered in England and Wales, registration number 10791545. The registered office is The Old Barn, Anchorage Lane, Sprotbrough, Doncaster, South Yorkshire, DN5 8DT.
2
Compliance with accounting standards
The accounts have been prepared in accordance with the provisions of FRS 102 Section 1A Small Entities. There were no material departures from that standard.
3
Accounting policies
The principal accounting policies adopted in the preparation of the financial statements are set out below and have remained unchanged from the previous period, and also have been consistently applied within the same accounts.
Basis of preparation
The accounts have been prepared under the historical cost convention as modified by the revaluation of certain fixed assets.
Presentation currency
The accounts are presented in £ sterling.
Tangible fixed assets and depreciation
Tangible assets are included at cost less depreciation and impairment. Depreciation has been provided at the following rates in order to write off the assets over their estimated useful lives:
Plant & machinery
25% reducing balance
Computer equipment
40% reducing balance
Other tangible fixed assets
0%
Intangible fixed assets
Intangible fixed assets (including purchased goodwill and patents) are included at cost less accumulated amortisation.
4
Intangible fixed assets
Total 
£ 
Cost
At 1 June 2022
3,110 
At 31 December 2022
3,110 
Amortisation
At 1 June 2022
- 
At 31 December 2022
- 
Net book value
At 31 December 2022
3,110 
At 31 May 2022
3,110 
- 6 -
Unium Bioscience Ltd Notes to the Accounts for the period from 1 June 2022 to 31 December 2022
5
Tangible fixed assets
Total 
£ 
Cost or valuation
At 1 June 2022
11,690 
Additions
2,273 
At 31 December 2022
13,963 
Depreciation
At 1 June 2022
6,606 
Charge for the period
1,540 
At 31 December 2022
8,146 
Net book value
At 31 December 2022
5,817 
At 31 May 2022
5,084 
6
Average number of employees
During the period the average number of employees was 2 (31/05/2022: 2).
- 7 -